secwatch.observer — SEC 8-K summary
======================================

Issuer:     THERMO FISHER SCIENTIFIC INC. (TMO)
CIK:        0000097745
Form:       8-K
Filed at:   2022-04-28T23:59:59+00:00
Accession:  0000097745-22-000022
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Thermo Fisher Q1 revenue $11.82B (+19%), adjusted EPS $7.25; raises dividend 15%
--------------------------------------------------------------------------------

- GAAP EPS $5.61 vs $5.88 last year; adjusted EPS $7.25 vs $7.21.
- Core organic growth 16%; COVID-19 testing revenue $1.68B.
- Repurchased $2.0B of stock and increased dividend by 15%.
- PPD clinical research business integration proceeding smoothly.
- Moderna entered 15-year strategic collaboration for mRNA manufacturing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/97745/000009774522000022/0000097745-22-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/97745/000009774522000022/tmo-20220428.htm
  HTML page:      https://secwatch.observer/filing/0000097745-22-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer